Submission of Annual Secretarial Compliance Report for the year ended March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Venmax Drugs and Pharmaceuticals Ltd has submitted its Annual Secretarial Compliance Report to BSE for the financial year ended March 31, 2026. This is a mandatory yearly filing required under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, where the Practicing Company Secretary certifies whether the company has complied with applicable SEBI rules, regulations, and circulars during the year. The actual report content was not accessible as the linked BSE page returned an error. No specific compliance deviations, penalties, or observations are available from the source.
This is a routine annual regulatory compliance submission and typically has no material impact on the stock price unless the report flags non-compliance or significant observations, which cannot be confirmed from the available information.